Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers by Grabiec, Aleksander et al.
Eur. J. Immunol. 2018. 48: 855–860 Aleksander M. Grabiec et al.DOI: 10.1002/eji.201747283 855
B
asic
Immunity to infection
Short Communication
Axl and MerTK receptor tyrosine kinases maintain
human macrophage efferocytic capacity in the presence
of viral triggers
Aleksander M Grabiec1,2 , Anu Goenka2, Mark E Fife2,
Toshifumi Fujimori2 and Tracy Hussell2
1 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology,
Jagiellonian University, Krako´w, Poland
2 Manchester Collaborative Centre for Inflammation Research, The University of Manchester,
Manchester, UK
The requirement to remove apoptotic cells is equally important in homeostasis and
inflammatory disease. In particular, during viral infections large quantities of infected
cells undergo apoptosis and need to be efficiently cleared by phagocytes to prevent
secondary necrosis. Although specific roles of several apoptotic cell sensors, such as
the TAM (Tyro3, Axl, MerTK) receptor family, have been characterized in mouse mod-
els, little is known about their regulation and involvement in apoptotic cell uptake
(efferocytosis) by human macrophages under inflammatory conditions. We show that
whereas pro-inflammatory stimuli consistently downregulated MerTK expression in
human monocyte-derived macrophages (MDMs), stimuli indicative of a viral infection,
interferon-α (IFN-α) and the TLR3 ligand poly(I:C), specifically induced Axl expression
and promoted binding of the bridging molecule Gas6. Axl induction by IFN-α and poly(I:C)
was associated with higher MDM efferocytic capacity compared to cells treated with other
pro-inflammatory stimuli, such as LPS and IFN-γ. While MerTK blocking antibody uni-
formly suppressed apoptotic cell uptake by MDMs, Axl blocking antibody significantly
reduced efferocytosis by poly(I:C)-stimulated MDMs, but not by resting MDMs. Our obser-
vations demonstrate that Axl induction during viral infections contributes to maintaining
macrophage capacity to engulf apoptotic cells, which may have important consequences
for resolution of anti-viral immune responses.
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Introduction
Macrophages regulate immune homeostasis through multiple
mechanisms, among which the timely removal of apoptotic cells
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plays a crucial role. Phagocytosis of apoptotic cells, called effe-
rocytosis, not only prevents secondary necrosis and the release
of pro-inflammatory necrotic cell debris, but also activates anti-
inflammatory signaling cascades in the phagocyte, thus facilitat-
ing resolution of inflammation and tissue repair [1, 2]. Disruption
of non-inflammatory uptake of apoptotic cells by macrophages
contributes significantly to the pathogenesis of several chronic
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inflammatory diseases, including systemic lupus erythematosus
[3], asthma, chronic obstructive pulmonary disease and idiopathic
pulmonary fibrosis [4].
In the last decade, great progress has beenmade in understand-
ing the molecular mechanisms of efferocytosis and new classes of
apoptotic cell recognition receptors have been identified. Phos-
phatidylserine (PtdSer) and other ‘eat-me’ signals exposed on
apoptotic cells are recognized by a plethora of receptors expressed
by phagocytes, including proteins specifically responsible for apop-
totic cell recognition, such as the TIM (T cell/transmembrane,
immunoglobulin, and mucin) and TAM (Tyro3, Axl and MerTK)
families [5, 6], as well as molecules involved in other processes,
such as the scavenger receptor CD36, the LPS receptor CD14
and the angiogenesis regulator BAI1 (brain-specific angiogene-
sis inhibitor-1) [1]. While some of them, such as TIM receptors,
act only as tethering receptors, engagement of others has anti-
inflammatory signaling consequences [4]. Apoptotic cell recogni-
tion by TAM receptors, through the bridging molecules Protein
S or growth arrest specific 6 (Gas6), leads to receptor phospho-
rylation and the induction of suppressor of cytokine signaling-1
(SOCS-1) and SOCS-3, which inhibit pro-inflammatory signaling
pathways triggered by cytokines and toll-like receptor (TLR) lig-
ands [6, 7]. Mice lacking multiple TAM receptors develop systemic
autoimmune disease [8] and important contributions of individ-
ual TAM family members to the resolution of inflammation have
recently been demonstrated in mouse models [9, 10].
In mice, MerTK is expressed on all mature tissue macrophages,
whereas Axl expression is restricted to specific macrophage pop-
ulations: alveolar/airway macrophages, Kupffer cells in the liver
and red pulp macrophages in the spleen [11, 12]. Axl is also upreg-
ulated on murine macrophages by inflammatory stimuli [11, 12],
suggesting a central role for Axl in apoptotic cell clearance dur-
ing inflammation. Indeed, Axl-deficient alveolar macrophages dis-
play reduced efferocytic capacity and we have shown enhanced
morbidity to influenza virus infection in mice lacking Axl expres-
sion, associated with accumulation of dead cells in the lung [11].
However, comparatively little is known about the role of Axl in
apoptotic cell clearance by human macrophages. Studies of TAM
receptors in monocyte-derived macrophages (MDMs), which are
the most accessible and commonly used model for primary human
macrophages, have predominantly focused on MerTK, which is
highly expressed on differentiated MDMs and regulated by pro-
and anti-inflammatory mediators [13, 14]. The expression pat-
tern of Axl and its involvement in efferocytosis by MDMs remain
unknown. In this study, we show that specific induction of Axl
on MDMs by inflammatory stimuli associated with viral infections
contributes to macrophage capacity to engulf apoptotic cells.
Results and discussion
Viral triggers induce Axl expression on macrophages
and promote Gas6 binding
We initiated this study by profiling changes in expression of the
TAM receptors Axl and MerTK in M-CSF-differentiated MDMs
stimulated with a range of pro- and anti-inflammatory stimuli.
In line with previous reports [13, 14], dexamethasone treat-
ment caused upregulation of MerTK expression, whereas pro-
inflammatory signals caused its down-regulation (Fig. 1A and
B). AXL expression, on the other hand, was only up-regulated by
stimuli associated with viral infections: the TLR3 ligand poly(I:C)
or interferon-α (IFN-α) (Fig. 1C–E and Supporting Information
Fig. 1). The Axl and MerTK expression pattern was indepen-
dent of the MDM differentiation method: GM-CSF-differentiated
MDMs also expressed high levels of MerTK (albeit significantly
lower compared to M-CSF-differentiated MDMs) and low levels of
Axl (Fig. 1F–G), which were upregulated upon IFN-α or poly(I:C)
treatment (data not shown). Importantly, in all tested conditions
MDMs expressed negligible levels of Tyro3 mRNA (Fig. 1H), indi-
cating that Axl and MerTK are the sole TAM receptors involved in
efferocytosis by human macrophages. The bridging ligand Gas6 is
constitutively bound to Axl expressed on mouse and human alveo-
lar macrophages [11, 15] and, consistently, poly(I:C) stimulation
promoted increased binding of endogenously produced Gas6 to
MDMs (Fig. 1I–J), which may prime these cells for apoptotic cell
recognition via Axl. These observations indicate that upregulation
of Axl may partly compensate for reduced expression of MerTK to
maintain macrophage efferocytic capacity during viral infection.
The observation that induction of Axl by poly(I:C) and IFN-α
was associated with downregulation of MerTK also suggests that,
unlike mouse airway macrophages, which express high levels
of both Axl and MerTK [11], human macrophages preferen-
tially express elevated levels of either Axl or MerTK (or low
levels of both receptors) depending on the conditions or local
microenvironment. Consistently, we have shown that human air-
way macrophages constitutively express high levels of Axl, but not
MerTK [15]. The functional consequences of this reciprocal reg-
ulation remain unclear, but are important to elucidate in future
studies since Axl has higher affinity for the bridging ligand Gas6
compared to MerTK [6]. While TAM receptor activation is gener-
ally associated with anti-inflammatory responses [7], it is possible
that subtle differences in transcriptional programs triggered by Axl
and MerTK may exist and that Axl-induced signaling specifically
regulates resolution of viral infection-induced inflammation.
Inflammatory stimuli have differential effects on
efferocytosis by human macrophages
To gain more insight into the functional consequences of dif-
ferential Axl and MerTK regulation we analyzed the efferocytic
capacity of MDMs treated with pro- and anti-inflammatory stimuli
using pHrodo-labelled apoptotic Jurkat cell uptake as a model.
Untreated MDMs displayed high efferocytic capacity, which was
further enhanced by dexamethasone (Fig. 2A and B). This is
likely explained by increased MerTK expression after dexametha-
sone treatment [13, 14]. In contrast, efferocytosis in the presence
of LPS or IFN-γ was significantly less efficient with only 40%
of macrophages taking up apoptotic cells. Incubation of MDMs
with IFN-α or poly(I:C) resulted in a slight reduction of MDM
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Figure 1. Inflammatory stimuli associated with viral infections upregulate Axl and promote Gas6 binding to macrophages. (A–E) MDMs were
stimulated for 24 h with dexamethasone (Dex), LPS, IFN-γ, poly(I:C) or IFN-α. (A) MerTK and (C) Axl protein expression determined by ELISA of
total cell lysates (mean+SEM, n = 4). (B) MerTK and (D) Axl protein expression analyzed by western blotting; actin was used as loading control.
A representative of two to three independent experiments is shown. (E) Flow cytometric analysis of Axl expression on MDMs stimulated with
poly(I:C) or IFN-α for 24 h. Representative histograms of two independent experiments are shown; dotted line/shaded: FMO control. (F) Axl and
MerTK relative mRNA and (G) protein expression in MDMs differentiated by 6-day culture in M-CSF or GM-CSF determined by qPCR (mean+SEM,
n = 6) and by ELISA of total cell lysates (mean+SEM, n = 3), respectively. (H) Axl, MerTK and Tyro3 relative mRNA expression in MDMs stimulated
as in (A–C) analyzed by qPCR (mean+SEM, n = 2–3). (I and J) Flow cytometric analysis of Gas6 binding to MDMs stimulated with poly(I:C) for 24
h. (I) Representative of four independent experiments is shown; dotted line/shaded: isotype control. (J) Ratio of Gas6 to isotype control geometric
mean fluorescence intensity (MFI)+SEM in unstimulated and poly(I:C)-stimulated MDMs (n = 4). *p < 0.01, paired t-test. ELISA and qPCR samples
were assayed in duplicate.
efferocytic activity that was, however, less pronounced compared
to LPS or IFN-γ stimulation and did not reach statistical signif-
icance (Fig. 2A and B and Supporting Information Fig. 2). It is
interesting that different stimuli affect MDM efferocytic capac-
ity to varying degrees as it is believed that macrophage inflam-
matory stimulation globally reduces this function [16]. How-
ever, influenza virus is reported to increase efferocytic activity
of mouse alveolar macrophages during infection, which is depen-
dent on soluble factors released by apoptotic influenza-infected
cells [17]. Our results may thus reflect a specific process that
sustains macrophage capacity to engulf virus-infected cells under-
going apoptosis while mounting a rapid inflammatory response
to viral infection. We hypothesize that Axl, which is specifically
induced by IFN-α and TLR3 ligation in MDMs, is involved in this
process.
Axl facilitates apoptotic cell uptake by human
macrophages
To determine the relative contribution of Axl and MerTK to effe-
rocytosis by MDMs, we utilized Axl and MerTK-blocking antibod-
ies which prevent TAM receptor-mediated apoptotic cell uptake.
MerTK blocking antibody partly prevented apoptotic cell uptake
by both unstimulated and poly(I:C)-stimulated MDMs, suggesting
that even reduced levels of MerTK after poly(I:C) treatment signif-
icantly contribute to MDM efferocytosis. In contrast, Axl blocking
antibody alone or in combination with anti-MerTK antibody sig-
nificantly reduced apoptotic cell engulfment by MDMs only after
poly(I:C) stimulation, but not in unstimulated MDMs (Fig. 2C and
D). These findings suggest that, although MerTK plays the most
prominent role in apoptotic cell uptake by MDMs, selective induc-
tion of Axl by triggers associated with anti-viral responses might
contribute to the efferocytic capacity of macrophages during viral
infection or at sites which are frequently exposed to viral chal-
lenges. It should be noted that efferocytosis was not completely
blocked even after simultaneous treatment with Axl and MerTK
blocking antibodies, suggesting the involvement of other receptors
in this process.
Collectively, these observations imply that not only MerTK, but
also Axl expression and activity on human macrophages play an
important role during viral infections. Consistently, Axl-expressing
cells accumulate in the lungs of mice infected with influenza and
Axl is required for resolution of pulmonary inflammation upon
viral infection [11]. We show that Axl is induced on MDMs by
IFN-α and, from our previous research, Axl expression on human
alveolar macrophages is also likely dependent on IFN signal-
ing [15]. Axl is also induced by IFNs on murine dendritic cells [7]
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Figure 2. Axl contributes to efferocytosis by poly(I-C)-stimulated
macrophages. (A and B) Uptake of pHrodo-labeled apoptotic Jurkat cells
by MDMs stimulated as in Fig. 1A analyzed by flow cytometry. MDMs
treated with cytochalasin D (Cyto D) were used as negative control. (A)
Representative histograms and (B) the mean percentage of phagocytic
MDMs+SEM (n = 5) are shown. *p < 0.05, **p < 0.01, One-way ANOVA
followed by Bonferroni multiple comparison test. (C and D) Uptake of
pHrodo-labeled apoptotic Jurkat cells by MDMs that were left unstim-
ulated or were stimulated for 24 h with poly(I:C) in the presence of
control goat IgG, Axl blocking antibody, MerTK blocking antibody or a
combination of both. (C) Representative histograms and (D) the mean
percentage of phagocytic MDMs+SEM (n = 5) are shown. *p < 0.05, **p <
0.01, paired t-test.
and is involved in the generation of anti-viral T-cell immunity
and viral clearance [10], confirming an important role of the
IFN-Axl axis in the resolution of inflammation upon viral infection.
In a recent study, Zagorska et al. demonstrated that MerTK is the
main apoptotic cell recognition receptor in homeostasis, whereas
Axl mediates efferocytosis during inflammation [12]. Our data
suggest that while MerTK is the main regulator of efferocytosis
in human macrophages both under homeostatic and inflamma-
tory conditions, induction of Axl is specifically involved in apop-
totic cell clearance by cells exposed to viral triggers. It remains to
be tested if a similar specificity of Axl function can be observed
in human tissue macrophages during bacterial and viral infec-
tions, and whether compounds that upregulate Axl could facilitate
phagocytosis of virus-infected apoptotic cells. In that regard it is
noteworthy that treatment with type I IFN, which maintains Axl
expression on human airway macrophages [15], reduced disease
exacerbations related to respiratory viral infection in patients with
severe asthma [18]. Airway macrophages from these patients are
known to be defective in their efferocytic function [4].
Inhibition of Axl in the clinic is of high current interest due
its oncogenic function in hematological and epithelial malignan-
cies and a small-molecule Axl inhibitor BGB324 is currently being
evaluated in clinical trials [19]. However, in non-malignant con-
ditions, such as acute inflammation following viral infection, inhi-
bition of Axl may enhance inflammation by suppressing efficient
elimination of apoptotic cells by macrophages [10, 11]. Clinical
trials of Axl inhibitors should therefore be designed with caution.
Additional studies are also needed to delineate whether recogni-
tion of apoptotic cells by Axl and MerTK have different effects
on the resulting anti-inflammatory phenotype of macrophages,
and characterize the roles of Axl expressed on human tis-
sue macrophages, such as alveolar macrophages, during viral
infections.
Concluding remarks
Apoptotic cells that are not cleared undergo secondary necrosis
that adds to the inflammatory environment. It is thus vital that a
process exists whereby the additional apoptotic burden caused by
inflammatory cell recruitment is dealt with. Our results indicate
that this is facilitated during viral infection by an upregulation of
the TAM receptor, Axl, which cooperates with the main apoptotic
cell sensor in human macrophages, MerTK, in maintaining their
efferocytic capacity. Many inflammatory diseases are prolonged
by inefficient apoptotic cell clearance which could be tackled by
administering therapeutics that up-regulate Axl, such as type I
interferons.
Materials and methods
Cell isolation and culture
Leukocyte cones with healthy donor peripheral blood were
obtained from the National Blood Transfusion Service (Manch-
ester, UK). Isolation of peripheral blood mononuclear cells
(PBMCs) was performed by Ficoll-Paque density gradient cen-
trifugation. Human CD14 MicroBeads (Miltenyi Biotec) were then
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used to purify monocytes from PBMCs by magnetic-activated cell
sorting. Monocytes were plated at 5 × 105 cells/mL in RPMI1640
medium containing 10% FCS, 100 U/mL penicillin, 100 μg/mL
streptomycin, 2 mM L-glutamine and 50 ng/mL M-CSF or
GM-CSF (both from Peprotech), and cultured for 6 days. After
differentiation into macrophages, culture medium was replaced
with M-CSF/GM-CSF-free medium and cells were stimulated with
with 50 ng/mL IFN-λ (Peprotech), 1000 U/mL IFN-α (R&D Sys-
tems), 50 μg/mL poly(I:C), 100 ng/mL LPS (both from Invivogen)
or 1 μM dexamethasone (Sigma-Aldrich) for 24 h. Blood collec-
tion and processing was approved by the University of Manchester
ethics committee.
Total Axl/MerTK ELISA and western blotting
Macrophages were lysed in lysis buffer containing 1% Igepal
CA-630, 20 mM Tris pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM
EDTA and protease inhibitor cocktail (Sigma-Aldrich). Axl and
MerTK protein levels were analyzed in cell lysates using total
(t)Axl and (t)MerTK, ELISA kits (R&D Systems) according to the
manufacturer’s instructions. Alternatively, protein expression was
determined by western blotting as described before [15] using
antibodies recognizing MerTK (D21F11) (Cell Signaling Technol-
ogy), Axl (M20) or actin (I19-R) (both from Santa Cruz Biotech-
nology). Membranes were visualized using a ChemiDoc MP Imag-
ing System (BIO-RAD).
RNA extraction and quantitative PCR (qPCR)
RNA was extracted using RNeasy micro kit (QIAGEN) and equal
amounts of RNA were reverse transcribed using High-Capacity
RNA-to-cDNA Kit (Life Technologies). qPCR reactions were per-
formed on a QuantStudio 12K Flex PCR system using TaqMan
Fast Universal PCR Master Mix and TaqMan expression assays
(all from Life Technologies). QuantStudio 12K Flex Software (Life
Technologies) was used for data analysis. mRNA expression of Axl,
MerTK and Tyro3 was calculated relative to average expression of
GAPDH and RPLP0.
Flow cytometric analyses
Macrophages were detached and stained with Zombie UV Flexible
Viability dye (BioLegend) for 20 min. Human TruStain FcX block-
ing solution (BioLegend) was then added for 10 min to block Fc
receptors. Cells werewashedwith FACS buffer (PBS supplemented
with 1% FCS and 2 mM EDTA), stained with APC-conjugated anti-
Axl (FAB154A) and biotinylated anti-Gas6 (BAF885) or control
biotinylated goat IgG (BAF108) antibodies (all from R&D Sys-
tems) for 20 min at 4°C, and washed again. Macrophages were
then incubated with BV421-conjugated streptavidin (BioLegend)
for 20 min at 4°C. After washing with FACS buffer cells were fixed
by 10 min incubation with 2% paraformaldehyde solution in PBS
and were acquired on a BD FACS Canto II. Results were analyzed
using FlowJo software. Gating strategy is shown in Supporting
Information Fig. 1.
Apoptotic cell uptake assay
Jurkat T cells were treated with 1 μM camptothecin (Merck-
Millipore) for 4 h to induce apoptosis and labeled with 100 ng/mL
pHrodo-SE (Life Technologies) for 30 min at 37°C. MDMs were
stimulated as described above or treated with control goat IgG
(AB-108-C, 5 μg/mL), goat anti-MerTK (AF891, 2.5 μg/mL) or
goat anti-Axl (AF154, 5 μg/mL) antibodies (all from R&D Sys-
tems) in the presence or absence of poly(I:C) for 24h prior to
incubation with apoptotic cells (5:1 ratio of apoptotic cells:MDMs)
for 60 min. Cells were detached and analyzed on a BD FACS Canto
II (BD Biosciences). MDMs treated with 5 μg/mL cytochalasin D
(Sigma-Aldrich) were used as a negative control and percentages
of phagocytic macrophages were calculated using FlowJo software
(TreeStar). Gating strategy is shown in Supporting Information
Fig. 2.
Statistical analyses
Data are presented as the mean±SEM. Parametric tests (paired
t-tests or one-way ANOVA) were used for comparisons between
groups. p values <0.05 were considered statistically significant.
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